Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126544541 | 12654454 | 1 | I | 20160815 | 20160816 | 20160816 | EXP | US-ROCHE-1813969 | ROCHE | 0.00 | F | Y | 0.00000 | 20160816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126544541 | 12654454 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Unknown | U | 103976 | 300 | MG | /month | |||||||
| 126544541 | 12654454 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126544541 | 12654454 | 1 | Product used for unknown indication |
| 126544541 | 12654454 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126544541 | 12654454 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126544541 | 12654454 | Epistaxis | |
| 126544541 | 12654454 | Lethargy | |
| 126544541 | 12654454 | Myalgia | |
| 126544541 | 12654454 | Pyrexia | |
| 126544541 | 12654454 | Vocal cord disorder | |
| 126544541 | 12654454 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |